These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 31689713)

  • 1. Evidence for Accelerated Biological Aging in Young Adults with Prader-Willi Syndrome.
    Donze SH; Codd V; Damen L; Goedegebuure WJ; Denniff M; Samani NJ; van der Velden JAEM; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2020 Jun; 105(6):2053-9. PubMed ID: 31689713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of size at birth, childhood growth patterns and growth hormone treatment on leukocyte telomere length.
    Smeets CC; Codd V; Denniff M; Samani NJ; Hokken-Koelega AC
    PLoS One; 2017; 12(2):e0171825. PubMed ID: 28178350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
    Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
    Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
    Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
    Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
    Trueba-Timmermans DJ; Grootjen LN; Juriaans AF; Mahabier EF; Kerkhof GF; Rings EHHM; Hokken-Koelega ACS
    Eur J Endocrinol; 2023 Jul; 189(1):132-139. PubMed ID: 37440711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.
    Donze SH; Kuppens RJ; Bakker NE; van Alfen-van der Velden JAEM; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):806-812. PubMed ID: 29418016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic health profile in young adults with Prader-Willi syndrome: results of a 2-year randomized, placebo-controlled, crossover GH trial.
    Kuppens RJ; Bakker NE; Siemensma EP; Donze SH; Stijnen T; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):297-304. PubMed ID: 27689944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte Telomere Length in Young Adults Born Preterm: Support for Accelerated Biological Ageing.
    Smeets CC; Codd V; Samani NJ; Hokken-Koelega AC
    PLoS One; 2015; 10(11):e0143951. PubMed ID: 26619005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity.
    Goldstone AP; Unmehopa UA; Swaab DF
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):743-55. PubMed ID: 12780752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of GH in Young Adults With Prader-Willi Syndrome: A 2-Year Crossover Trial.
    Kuppens RJ; Bakker NE; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Donze SH; Festen DA; van Alfen-van der Velden JA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4110-4116. PubMed ID: 27552545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone receptor (GHR) gene polymorphism and scoliosis in Prader-Willi syndrome.
    Butler MG; Hossain W; Hassan M; Manzardo AM
    Growth Horm IGF Res; 2018 Apr; 39():29-33. PubMed ID: 29273483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls.
    Grugni G; Marostica E; Crinò A; Marzullo P; De Nicolao G; Sartorio A
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):224-31. PubMed ID: 23301953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey matter volume and cortical structure in Prader-Willi syndrome compared to typically developing young adults.
    Manning KE; Tait R; Suckling J; Holland AJ
    Neuroimage Clin; 2018; 17():899-909. PubMed ID: 29527494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome.
    van Nieuwpoort IC; Sinnema M; Castelijns JA; Twisk JW; Curfs LM; Drent ML
    Horm Res Paediatr; 2011; 75(6):403-11. PubMed ID: 21273761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adults with Prader-Willi syndrome have weaker bones: effect of treatment with GH and sex steroids.
    Longhi S; Grugni G; Gatti D; Spinozzi E; Sartorio A; Adami S; Fanolla A; Radetti G
    Calcif Tissue Int; 2015 Feb; 96(2):160-6. PubMed ID: 25577526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.